pet care
Pet Health Explodes: Elanco's Q1 2026 Revenue Surge
Elanco’s Q1 2026 earnings surged, delivering $5.2 billion in revenue and lifting the stock 12% in early trade, signaling a strong upturn for pet health products. The boost came from higher demand for veterinary drugs and wellness solutions across U.S. markets. Revenue climbed 14% year-over-year to $5.